The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative

AIM: To investigate the association between vasculopathy and survival during experimental cerebral malaria (ECM), and to determine whether targeting the endothelin-1 (ET-1) pathway alone or in combination with the anti-malaria drug artemether (a semi-synthetic derivative of artemisinin) will improve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dai, Minxian, Freeman, Brandi, Bruno, Fernando P., Shikani, Henry J., Tanowitz, Herbert B., Weiss, Louis M., Reznik, Sandra E., Stephani, Ralph A., Desruisseaux, Mahalia S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523882/
https://ncbi.nlm.nih.gov/pubmed/22820174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2012.07.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller